Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Bioceres Crop Solutions ( (BIOX) ).
On March 13, 2026, Bioceres Crop Solutions filed a Form 6-K with the U.S. Securities and Exchange Commission, providing unaudited interim condensed consolidated financial statements. The filing covers the company’s financial position as of December 31, 2025 and June 30, 2025, and results for the three- and six-month periods ended December 31, 2025 and 2024.
The disclosure gives investors updated visibility into Bioceres’ assets, liabilities, equity and cash flows midway through its 2025–26 fiscal cycle. While the document is primarily technical, it forms part of the company’s regular SEC reporting and supports ongoing access to U.S. capital markets by refreshing financial information used in existing shelf and employee equity plans.
The most recent analyst rating on (BIOX) stock is a Sell with a $0.57 price target. To see the full list of analyst forecasts on Bioceres Crop Solutions stock, see the BIOX Stock Forecast page.
Spark’s Take on BIOX Stock
According to Spark, TipRanks’ AI Analyst, BIOX is a Neutral.
The score is held back primarily by weakening revenue and ongoing losses combined with higher leverage, despite some improvement in cash flow and margin efficiency. Technical signals remain bearish (below key moving averages with negative MACD), and valuation lacks support due to negative earnings and no dividend.
To see Spark’s full report on BIOX stock, click here.
More about Bioceres Crop Solutions
Bioceres Crop Solutions Corp. is an Argentina-based agricultural biotechnology company focused on crop productivity and sustainability. The group develops and commercializes seeds, biologicals, and integrated agronomic solutions aimed at improving yields and resource efficiency for farmers in key global agricultural markets.
Average Trading Volume: 843,391
Technical Sentiment Signal: Sell
Current Market Cap: $38.28M
Learn more about BIOX stock on TipRanks’ Stock Analysis page.